A. Jo Dicke < A. Jon Stoessl < A. Jones

Facettes :

List of bibliographic references indexed by A. Jon Stoessl

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000247 (2011)	A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]	Milestones in neuroimaging
000401 (2011)	Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
000E19 (2008)	W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]	Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease
000F43 (2007)	Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]	Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
001069 (2007)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study
001214 (2006)	Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis]	Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease
001301 (2006)	Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]	Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation
001612 (2004)	Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
001679 (2003)	Ajit Kumar ; Sharanpal Mann ; Vesna Sossi ; Thomas J. Ruth ; A. Jon Stoessl ; Michael Schulzer ; Chong S. Lee	[11C]DTBZ‐PET correlates of levodopa responses in asymmetric Parkinson’s disease
001708 (2003)	Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
001808 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]	Age and severity of nigrostriatal damage at onset of Parkinson's disease
001B06 (2001)	Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
001B95 (2000)	Raúl De La Fuente-Fernández [Canada] ; Asha Kishore [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Nigrostriatal dopamine system and motor lateralization
001C40 (2000)	J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity

---

List of associated KwdEn.i

Nombre de documents	Descripteur
3	Parkinson's disease
2	PET
2	levodopa
1	6‐hydroxydopamine
1	Abbreviations: BP = binding potential; DA = dopamine; [11C]DTBZ = [11C](±)dihydrotetrabenazine; Emax = magnitude of levodopa response; EC50 = levodopa concentration producing 50% of the maximal response; ROI = region of interest; T1/2eq = equilibration half‐life
1	BP = binding potential
1	Caud = caudate nucleus
1	Caudate nucleus
1	Dorsolateral prefrontal cortex
1	Fluorodopa
1	Handedness
1	Huntington disease
1	Keywords: Parkinson’s disease; PET; motor fluctuations; levodopa; dihydrotetrabenazine
1	MCS = modified Columbia Scale
1	MPP+
1	P1, P2 and P3 = rostral to caudal putamen
1	Parkinson's
1	Parkinson’s disease
1	Positron emission tomography
1	Putamen
1	RAC = [11C]raclopride
1	ROI = region of interest
1	Supplementary motor area
1	[11C]dihydrotetrabenazine
1	[11C]methylphenidate
1	[18F]fluorodopa
1	amphetamine
1	deep brain stimulation
1	dopamine
1	dopamine agonist
1	dopamine release
1	dyskinesia
1	dyskinesias
1	dystonia
1	fluctuations
1	motor complications
1	neurotoxicity
1	nocebo
1	placebo
1	positron emission tomography
1	raclopride
1	ropinirole
1	subthalamic nucleus
1	treatment
1	wearing off

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "A. Jon Stoessl" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "A. Jon Stoessl" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    A. Jon Stoessl
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024